These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 28869522

  • 1. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC.
    Toxins (Basel); 2017 Sep 03; 9(9):. PubMed ID: 28869522
    [Abstract] [Full Text] [Related]

  • 2. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3.
    Webb RP, Smith TJ, Wright P, Brown J, Smith LA.
    Vaccine; 2009 Jul 16; 27(33):4490-7. PubMed ID: 19450643
    [Abstract] [Full Text] [Related]

  • 3. Potency and stability of a trivalent, catalytically inactive vaccine against botulinum neurotoxin serotypes C, E and F (triCEF).
    Webb R, Wright PM, Brown JL, Skerry JC, Guernieri RL, Smith TJ, Stawicki C, Smith LA.
    Toxicon; 2020 Mar 16; 176():67-76. PubMed ID: 32032587
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ, Li N, Wang RL, Zhu HQ, Wang S, Yu WY, Sun ZW.
    Clin Vaccine Immunol; 2008 Dec 16; 15(12):1819-23. PubMed ID: 18845829
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vaccines against botulism.
    Karalewitz AP, Barbieri JT.
    Curr Opin Microbiol; 2012 Jun 16; 15(3):317-24. PubMed ID: 22694934
    [Abstract] [Full Text] [Related]

  • 9. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB.
    Hum Vaccin Immunother; 2020 Jun 16; 16(1):100-108. PubMed ID: 31210561
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
    Khouri JM, Motter RN, Arnon SS.
    Vaccine; 2018 Apr 05; 36(15):2041-2048. PubMed ID: 29475762
    [Abstract] [Full Text] [Related]

  • 11. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
    Gao YL, Gao S, Kang L, Nie C, Wang JL.
    Hum Vaccin; 2010 Jun 05; 6(6):462-6. PubMed ID: 20519939
    [Abstract] [Full Text] [Related]

  • 12. Production of recombinant botulism antigens: a review of expression systems.
    Moreira GM, Cunha CE, Salvarani FM, Gonçalves LA, Pires PS, Conceição FR, Lobato FC.
    Anaerobe; 2014 Aug 05; 28():130-6. PubMed ID: 24930432
    [Abstract] [Full Text] [Related]

  • 13. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
    Yu YZ, Zhang SM, Ma Y, Zhu HQ, Wang WB, Du Y, Zhou XW, Wang RL, Wang S, Yu WY, Huang PT, Sun ZW.
    Clin Immunol; 2010 Nov 05; 137(2):271-80. PubMed ID: 20696619
    [Abstract] [Full Text] [Related]

  • 14. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J.
    Front Immunol; 2024 Nov 05; 15():1469919. PubMed ID: 39315101
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R, Zhao H, Al-Saleem FH, Ubaid AS, Puligedda RD, Segan AT, Lindorfer MA, Bermudez R, Elias M, Adekar SP, Simpson LL, Taylor RP, Dessain SK.
    Mol Immunol; 2014 Feb 05; 57(2):247-54. PubMed ID: 24184879
    [Abstract] [Full Text] [Related]

  • 17. Development of vaccines for prevention of botulism.
    Byrne MP, Smith LA.
    Biochimie; 2000 Feb 05; 82(9-10):955-66. PubMed ID: 11086225
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.